← SynDRA
BMS-779788
SynDRA canonical compound SYN0038126 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | NR1H2 |
|---|
| Mechanism of action | LXR agonist |
|---|
All known targets
Mechanisms of action (all sources)
- NR1H2 AGONIST
- LXR-beta agonist
- LXR agonist
Cross-references
Synonyms
- BMS 788
- EXEL-04286652
- XL-652
- XL-014
- FB7ZTJ8M8A
- XL 652
- RefChem:120742
- BMS-779788(XL-652)
- 4rak
- MFCD30532752
- UNII-FB7ZTJ8M8A
- C28H29ClN2O3S
- SCHEMBL799993
- orb1303495
- SCHEMBL30277836
- GLXC-10165
- EX-A5104
- TLB34867
- BDBM50034775
- AKOS032945035
- CS-6167
- AC-38051
- DA-71587
- HY-19919
- MS-29454
- N16812
- 2-{2-[2-(2-chlorophenyl)propan-2-yl]-1-[3'-(methylsulfonyl)biphenyl-4-yl]-1H-imidazol-4-yl}propan-2-ol
Look up BMS-779788 in the interactive SynDRA portal →